PODD Share Price Performance
US$284.91
94.33 (49.50%)
16.2% undervalued intrinsic discount
US$340.13
Fair Value
Price US$284.91
AnalystConsensusTarget US$340.13
Fair ValueUS$340.13
Share PriceUS$284.91
16.2% undervalued intrinsic discount
PODD Community Narratives
AN
Fair Value US$340.13 16.2% undervalued intrinsic discount
FDA Clearance And Global Rollout Of Omnipod 5 Will Expand Market Reach
0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
PODD Community Fair Values
- US$340.13FV16.2% undervalued intrinsic discount17.43%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative11users have followed this narrative4 days ago author updated this narrative
Recent PODD News & Updates
No updates
Insulet Corporation Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 07, 2025
- Earnings per share (EPS)
- 5.72
- Gross Margin
- 70.39%
- Net Profit Margin
- 18.29%
- Debt/Equity Ratio
- 127.4%
Insulet Corporation Competitors
About PODD
- Founded
- 2000
- Employees
- 3900
- CEO
- WebsiteView website
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
U.S. Market Performance
- 7 Days: -2.7%
- 3 Months: 11.4%
- 1 Year: 20.5%
- Year to Date: 5.9%
Over the last 7 days, the market has dropped 2.7%, driven by a pullback of 2.4% in the Information Technology sector. In contrast to the last week, the market is actually up 20% over the past year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading